HUMAN RECOMBINANT LIPOCORTIN-1 HAS ACUTE LOCAL ANTI-INFLAMMATORY PROPERTIES IN THE RAT PAW EDEMA TEST
HUMAN RECOMBINANT LIPOCORTIN-1 HAS ACUTE LOCAL ANTI-INFLAMMATORY PROPERTIES IN THE RAT PAW EDEMA TEST
复制标题
DOI:
10.1073/pnas.86.9.3428
复制
发表时间:
1989-05-01
影响因子:
11.1
通讯作者:
PEPINSKY, RB
中科院分区:
文献类型:
--
作者:
CIRINO, G;PEERS, SH;PEPINSKY, RB
Human recombinant lipocortin 1 has been tested for anti-inflammatory activity in a conventional model of acute inflammation. Microgram amounts of the protein, locally administered, inhibited edema of the rat paw when induced by subplantar injections of carrageenin: the ED50 was 10-20 .mu.g per paw, and inhibition (maximum of 60-70%) was not dependent upon an intact adrenal cortex. Doses of lipocortin that produced .apprxeq. 50% inhibition in the carrageenin test were inactive against edema elicited by bradykinin, serotonin, platelet-activating factor-acether, or dextran, whereas edema caused by Naja mocambique venom phospholipase A2 was strongly inhibited by lipocortin. The protein inhibited edema when rats were pretreated with agents that depleted mast-cell amines, kininogen, or polymorphonuclear leukocytes prior to initiation of the carrageenin edema but had no inhibitory action when rats were pretreated with the dual cyclooxygenase/lipoxygenase inhibitor BW 755C. These results demonstrate that human recombinant lipocortin has potent local antiinflammatory activity, probably through selectively interfering with eicosanoid generation. Lipocortin is relatively ineffective against edema caused by mast-cell degranulation or kinins, except when degranulation is caused by phospholipase A2.